Fatty acid-like Pt(IV) prodrugs overcome cisplatin resistance in ovarian cancer by harnessing CD36

MLA

Zihan Qiu, et al. “Fatty Acid-like Pt(IV) Prodrugs Overcome Cisplatin Resistance in Ovarian Cancer by Harnessing CD36.” Chemical Communications (Cambridge, England), vol. 56, no. 73, Aug. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....27b33ef2b7c1099d8c2bc15687b04a7c&authtype=sso&custid=ns315887.

APA

Zihan Qiu, Amarasooriya M. D. S. Jayawardhana, Morgan Stilgenbauer, Han Wang, Yao-Rong Zheng, Payel Datta, Manabu Kurokawa, Sarine Mckenzie, & David J. Bowers. (2020). Fatty acid-like Pt(IV) prodrugs overcome cisplatin resistance in ovarian cancer by harnessing CD36. Chemical Communications (Cambridge, England), 56(73).

Chicago

Zihan Qiu, Amarasooriya M. D. S. Jayawardhana, Morgan Stilgenbauer, Han Wang, Yao-Rong Zheng, Payel Datta, Manabu Kurokawa, Sarine Mckenzie, and David J. Bowers. 2020. “Fatty Acid-like Pt(IV) Prodrugs Overcome Cisplatin Resistance in Ovarian Cancer by Harnessing CD36.” Chemical Communications (Cambridge, England) 56 (73). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....27b33ef2b7c1099d8c2bc15687b04a7c&authtype=sso&custid=ns315887.